# evismo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evismo

- Industry: Medical Devices & Equipment
- Headquarters: Zurich, Switzerland
- Website: www.evismo.com
- Total disclosed funding: $1.1M
- Latest round: Seed (Jul 29, 2021)
- Investors on record: 3

## About

Based in Zurich, Switzerland, and founded in 2018 by Willemien van den Toorn and Alexander Panos, Evismo AG, a.k.a. Evismo operates as a developer of remote vital signs monitoring platform, offering online holter service that improves access, diagnosis, treatment, and prevention for patients with suspected arrhythmias. In September 2021, Evismo AG raised CHF 1 million in seed funding from Zuhlke Ventures and individual investors.

The company provides CardioFlex, the 18-gram electrocardiogram (ECG) device integrated with medical sensors and software which can be applied to the skin with a patch for offering maximum diagnostic certainty for cardiac arrhythmias. The device can be worn for as long as necessary and for short a time as possible so that the patients receive a fast diagnosis in one measurement. Referrers receive the ECG analysis report directly on its platform.

## Funding rounds

- Seed, Jul 29, 2021, $1.1M — Zuhlke Ventures, Business Angels Suisse, Swiss Health Angels

## Investors

- Zuhlke Ventures (https://capitalatlas.ai/funds/zuhlke-ventures) — Seed
- Business Angels Suisse — Seed
- Swiss Health Angels (https://capitalatlas.ai/funds/swiss-health-angels) — Seed